Industry Strength Score
47/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
CENCORA INC (ABG.DE) Stock Price & Overview
FRA:ABG • US03073E1055
Current stock price
304.15 EUR
-5.95 (-1.92%)
Last:
The current stock price of ABG.DE is 304.15 EUR. Today ABG.DE is down by -1.92%. In the past month the price increased by 2.86%.
ABG.DE Key Statistics
1-Month Range284 - 321.5
Current ABG.DE stock price positioned within its 1-month range.
- Market Cap
- 59.166B
- P/E
- 21.51
- Fwd P/E
- 17.67
- EPS (TTM)
- 14.14
- Dividend Yield
- 0.72%
ABG.DE Stock Performance
Today
-1.92%
1 Week
-2.86%
1 Month
+2.86%
3 Months
-5.66%
Longer-term
6 Months N/A
1 Year N/A
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A
ABG.DE Stock Chart
ABG.DE Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to ABG.DE.
Chartmill TA Rating
Chartmill Setup Rating
ABG.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to ABG.DE. ABG.DE has an average financial health and profitability rating.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ABG.DE Earnings
On February 4, 2026 ABG.DE reported an EPS of 4.08 and a revenue of 85.93B. The company beat EPS expectations (0.03% surprise) and missed revenue expectations (-1.1% surprise).
Next Earnings DateMay 5, 2026
Last Earnings DateFeb 4, 2026
PeriodQ1 / 2026
EPS Reported$4.08
Revenue Reported85.932B
EPS Surprise 0.03%
Revenue Surprise -1.10%
ABG.DE Forecast & Estimates
22 analysts have analysed ABG.DE and the average price target is 332.07 EUR. This implies a price increase of 9.18% is expected in the next year compared to the current price of 304.15.
For the next year, analysts expect an EPS growth of 11.29% and a revenue growth 7.93% for ABG.DE
Analysts
Analysts82.73
Price Target332.07 (9.18%)
EPS Next Y11.29%
Revenue Next Year7.93%
ABG.DE Financial Highlights
Over the last trailing twelve months ABG.DE reported a non-GAAP Earnings per Share(EPS) of 14.14. The EPS increased by 14.99% compared to the year before.
Income Statements
Revenue(TTM)325.78B
Net Income(TTM)1.63B
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.5% | ||
| ROA | 2.07% | ||
| ROE | 85.16% | ||
| Debt/Equity | 3.97 |
Chartmill High Growth Momentum
EPS Q2Q%9.38%
Sales Q2Q%5.45%
EPS 1Y (TTM)14.99%
Revenue 1Y (TTM)7.45%
ABG.DE Ownership
Ownership
Inst Owners96.15%
Shares194.53M
Float186.27M
Ins Owners0.09%
Short Float %N/A
Short RatioN/A
ABG.DE Industry Overview
ABG.DE operates in the Health Care Distributors sub-industry within the Health Care sector. This group contains 7 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
8/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
55%
Outperformed 55% of sub-industries
3 Month Rank
52%
Outperformed 52% of sub-industries
6 Month Rank
43%
Outperformed 43% of sub-industries
Industry Fundamentals & Breadth
- Members
- 7
- New Highs
- 14.3%
- New Lows
- 0%
- Average ROE
- 76.2%
- Average Profit Margin
- 0.9%
- Average Operating Margin
- 1.5%
- Average P/E
- 19.8
- Average Fwd P/E
- 16.5
- Average Debt/Equity
- 3.5
ABG.DE Competitors/Peers
The largest stocks on the EU markets in the "Health Care Distributors" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| AMP | AMPLIFON SPA | 14.18 | 2.135B | ||
| AXNA | AMPLIFON SPA | 13.62 | 2.044B | ||
| FAGR | FAGRON | 15.96 | 1.77B | ||
| UPR | UNIPHAR PLC | 15.97 | 1.064B | ||
| ILM1 | MEDIOS AG | 10.94 | 348.977M | ||
| BLC | BASTIDE LE CONFORT MEDICAL | 12.17 | 184.618M | ||
| VME | VIROMED MEDICAL AG | N/A |
Related stock screener links
View all stocks in the Health Care Distributors Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About ABG.DE
Company Profile
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Company Info
IPO: 1996-05-28
CENCORA INC
1 West First Avenue
Conshohocken PENNSYLVANIA US
Employees: 44000
Phone: 13026587581
CENCORA INC / ABG.DE FAQ
What does ABG do?
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 51,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
What is the current price of ABG stock?
The current stock price of ABG.DE is 304.15 EUR. The price decreased by -1.92% in the last trading session.
Does CENCORA INC pay dividends?
CENCORA INC (ABG.DE) has a dividend yield of 0.72%. The yearly dividend amount is currently 1.95.
What is the ChartMill technical and fundamental rating of ABG stock?
ABG.DE has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
On which exchange is ABG.DE stock listed?
ABG.DE stock is listed on the Frankfurt Stock Exchange exchange.
What is the employee count for ABG stock?
CENCORA INC (ABG.DE) currently has 44000 employees.